🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

7 recruiting trials

for AIHA - Warm Autoimmune Hemolytic Anemia

Study to Assess the Safety and Tolerability of Tafasitamab in Adult Participants With Primary Autoimmune Blood Cell Disorders NCT07104565Phase 239 sites📍 Glendale📍 Los Angeles📍 Lone Tree Incyte Corporation · Tests: INCA000585 OM336 in Autoimmune Cytopenias NCT07083960Phase 17 sites📍 Duarte📍 Washington D.C.📍 Ann Arbor Lakefront Biotherapeutics West LLC · Tests: OM336 National Longitudinal Cohort of Hematological Diseases- Autoimmune Hemolytic Anemia NCT07019038n/a1 site📍 Tianjin Institute of Hematology & Blood Diseases Hospital, China · Tests: A combined retrospective and prospective observational follow-up A Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Oral Rilzabrutinib Compared With Placebo in Participants 18 Years of Age and Older With Warm Autoimmune Hemolytic Anemia NCT07086976Phase 3105 sites📍 Phoenix📍 Tucson📍 Duarte Sanofi · Tests: rilzabrutinib, placebo Sirolimus in the Treatment of Refractory/Relapsed wAIHA NCT05925023NA1 site📍 Beijing Peking Union Medical College Hospital · Tests: Sirolimus UCAR T-cell Therapy Targeting CD19/BCMA in Relapsed/Refractory Autoimmune Hemolytic Anemia NCT07530380EARLY Phase 11 site📍 Hefei The Second Hospital of Anhui Medical University · Tests: QT-219C Cell Injection Safety and Preliminary Efficacy of CTX112 in Adult Participants With Relapsed/Refractory Hematologic Autoimmune Disease NCT07549698Phase 1, Phase 212 sites📍 Boston📍 Rochester📍 Omaha CRISPR Therapeutics AG · Tests: CTX112
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy